These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 9756785

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. In vitro susceptibilities of Aspergillus species to voriconazole, itraconazole, and amphotericin B.
    Abraham OC, Manavathu EK, Cutright JL, Chandrasekar PH.
    Diagn Microbiol Infect Dis; 1999 Jan; 33(1):7-11. PubMed ID: 9990469
    [Abstract] [Full Text] [Related]

  • 5. In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Aspergillus spp. determined by CLSI and EUCAST broth microdilution methods.
    Pfaller MA, Duncanson F, Messer SA, Moet GJ, Jones RN, Castanheira M.
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5155-8. PubMed ID: 21844312
    [Abstract] [Full Text] [Related]

  • 6. In-vitro activity of the new triazole D0870 compared with amphotericin B and itraconazole against Aspergillus spp.
    Moore CB, Law D, Denning DW.
    J Antimicrob Chemother; 1993 Dec; 32(6):831-6. PubMed ID: 8144422
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses.
    Öz Y, Özdemir HG, Gökbolat E, Kiraz N, Ilkit M, Seyedmousavi S.
    Mycopathologia; 2016 Apr; 181(3-4):225-33. PubMed ID: 26612621
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vitro activity of caspofungin combined with sulfamethoxazole against clinical isolates of Aspergillus spp.
    Yekutiel A, Shalit I, Shadkchan Y, Osherov N.
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3279-83. PubMed ID: 15328085
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Intrinsic in vitro susceptibility of primary clinical isolates of Aspergillus fumigatus, Aspergillus terreus, Aspergillus nidulans, Candida albicans and Candida lusitaniae against amphotericin B.
    Singh J, Rimek D, Kappe R.
    Mycoses; 2006 Mar; 49(2):96-103. PubMed ID: 16466441
    [Abstract] [Full Text] [Related]

  • 14. Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species.
    Arikan S, Lozano-Chiu M, Paetznick V, Nangia S, Rex JH.
    J Clin Microbiol; 1999 Dec; 37(12):3946-51. PubMed ID: 10565912
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of increasing inoculum sizes of Aspergillus hyphae on MICs and MFCs of antifungal agents by broth microdilution method.
    Lass-Flörl C, Speth C, Kofler G, Dierch MP, Gunsilius E, Würzner R.
    Int J Antimicrob Agents; 2003 Mar; 21(3):229-33. PubMed ID: 12636983
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In vitro activity of voriconazole, itraconazole, caspofungin, anidulafungin (VER002, LY303366) and amphotericin B against aspergillus spp.
    Serrano Mdel C, Valverde-Conde A, Chávez M M, Bernal S, Claro RM, Pemán J, Ramirez M, Martín-Mazuelos E.
    Diagn Microbiol Infect Dis; 2003 Feb; 45(2):131-5. PubMed ID: 12614985
    [Abstract] [Full Text] [Related]

  • 19. Susceptibility of environmental versus clinical strains of pathogenic Aspergillus.
    Araujo R, Pina-Vaz C, Rodrigues AG.
    Int J Antimicrob Agents; 2007 Jan; 29(1):108-11. PubMed ID: 17189101
    [Abstract] [Full Text] [Related]

  • 20. A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592).
    Manavathu EK, Cutright JL, Loebenberg D, Chandrasekar PH.
    J Antimicrob Chemother; 2000 Aug; 46(2):229-34. PubMed ID: 10933645
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.